Transformer-Based Multi-Modal Temporal Embeddings for Explainable Metabolic Phenotyping in Type 1 Diabetes
By: Pir Bakhsh Khokhar , Carmine Gravino , Fabio Palomba and more
Potential Business Impact:
Finds hidden diabetes types for better health.
Type 1 diabetes (T1D) is a highly metabolically heterogeneous disease that cannot be adequately characterized by conventional biomarkers such as glycated hemoglobin (HbA1c). This study proposes an explainable deep learning framework that integrates continuous glucose monitoring (CGM) data with laboratory profiles to learn multimodal temporal embeddings of individual metabolic status. Temporal dependencies across modalities are modeled using a transformer encoder, while latent metabolic phenotypes are identified via Gaussian mixture modeling. Model interpretability is achieved through transformer attention visualization and SHAP-based feature attribution. Five latent metabolic phenotypes, ranging from metabolic stability to elevated cardiometabolic risk, were identified among 577 individuals with T1D. These phenotypes exhibit distinct biochemical profiles, including differences in glycemic control, lipid metabolism, renal markers, and thyrotropin (TSH) levels. Attention analysis highlights glucose variability as a dominant temporal factor, while SHAP analysis identifies HbA1c, triglycerides, cholesterol, creatinine, and TSH as key contributors to phenotype differentiation. Phenotype membership shows statistically significant, albeit modest, associations with hypertension, myocardial infarction, and heart failure. Overall, this explainable multimodal temporal embedding framework reveals physiologically coherent metabolic subgroups in T1D and supports risk stratification beyond single biomarkers.
Similar Papers
Use of Continuous Glucose Monitoring with Machine Learning to Identify Metabolic Subphenotypes and Inform Precision Lifestyle Changes
Machine Learning (CS)
Finds diabetes type by watching sugar spikes.
Lightweight Sequential Transformers for Blood Glucose Level Prediction in Type-1 Diabetes
Machine Learning (CS)
Predicts sugar levels to help diabetes patients.
A Machine Learning Framework for Pathway-Driven Therapeutic Target Discovery in Metabolic Disorders
Machine Learning (CS)
Finds diabetes risk and new medicine ideas.